Arrowhead Pharmaceuticals, Inc. financial reports, Arrowhead Pharmaceuticals, Inc. annual revenue in 2024. When does Arrowhead Pharmaceuticals, Inc. report revenue?
Arrowhead Pharmaceuticals, Inc. total revenue, net income and dynamics of changes in US dollar today
Arrowhead Pharmaceuticals, Inc. current income in US dollar. Arrowhead Pharmaceuticals, Inc. net revenue for today is 32 811 000 $. Arrowhead Pharmaceuticals, Inc. net income is now -26 818 000 $. Graph of the financial report of Arrowhead Pharmaceuticals, Inc.. The financial report schedule from 30/06/2017 to 31/03/2021 is available online. Arrowhead Pharmaceuticals, Inc. financial report on a graph in real time displays the dynamics, i.e. change in fixed assets of the company.
Report date
Total revenue
Total revenue refers to the total receipts from sales of a given quantity of goods or services. It is the total income of a business and is calculated by multiplying the quantity of goods sold by the price of the goods.
and
Change (%)
Comparing current quartal report this year to quartal report last year.
Net income
Net income is an entity's income minus cost of goods sold, expenses and taxes for an accounting period.
and
Change (%)
Comparing current quartal report this year to quartal report last year.
31/03/2021
32 811 000 $
-31.854 % ↓
-26 818 000 $
-212.223 % ↓
31/12/2020
21 303 000 $
-27.675 % ↓
-20 732 000 $
-
30/09/2020
7 632 855 $
-82.369 % ↓
-48 432 715 $
-513.781 % ↓
30/06/2020
27 375 778 $
-35.883 % ↓
-13 611 213 $
-166.933 % ↓
31/12/2019
29 454 579 $
-
-2 673 728 $
-
30/09/2019
43 292 770 $
-
11 704 905 $
-
30/06/2019
42 696 636 $
-
20 335 708 $
-
31/03/2019
48 148 275 $
-
23 896 982 $
-
31/12/2018
34 657 896 $
-
12 037 253 $
-
30/09/2018
11 255 000 $
-
-10 761 271 $
-
30/06/2018
727 375 $
-
-15 606 017 $
-
31/03/2018
650 125 $
-
-14 884 311 $
-
31/12/2017
3 509 821 $
-
-13 198 878 $
-
30/09/2017
8 713 786 $
-
-10 731 886 $
-
30/06/2017
9 342 498 $
-
-5 519 741 $
-
Show:
to
Arrowhead Pharmaceuticals, Inc. financial report charts
Dates of Arrowhead Pharmaceuticals, Inc. finance reports: 30/06/2017, 31/12/2020, 31/03/2021. The dates of financial statements are strictly regulated by law and financial statements. The current date of the financial report of Arrowhead Pharmaceuticals, Inc. for today is 31/03/2021. Gross profit Arrowhead Pharmaceuticals, Inc. is the profit a company makes after deducting the costs of making and selling its products, or the costs of providing its services. Gross profit Arrowhead Pharmaceuticals, Inc. is 32 811 000 $
Arrowhead Pharmaceuticals, Inc. quarterly report dates
Total revenue Arrowhead Pharmaceuticals, Inc. refers to the total receipts from sales of a given quantity of goods or services. It is the total income of a business and is calculated by multiplying the quantity of goods sold by the price of the goods. Total revenue Arrowhead Pharmaceuticals, Inc. is 32 811 000 $ Operating income Arrowhead Pharmaceuticals, Inc. is an accounting figure that measures the amount of profit realized from a business's operations, after deducting operating expenses such as wages, depreciation and cost of goods sold (COGS). Operating income Arrowhead Pharmaceuticals, Inc. is -28 232 000 $ Net income Arrowhead Pharmaceuticals, Inc. is an entity's income minus cost of goods sold, expenses and taxes for an accounting period. Net income Arrowhead Pharmaceuticals, Inc. is -26 818 000 $
Current assets Arrowhead Pharmaceuticals, Inc. is a balance sheet item that represents the value of all assets that can reasonably expect to be converted into cash within one year. Current assets Arrowhead Pharmaceuticals, Inc. is 586 757 000 $ Total assets Arrowhead Pharmaceuticals, Inc. refers to the total amount of assets owned by a person or entity. Total assets Arrowhead Pharmaceuticals, Inc. is 756 795 000 $ Current cash Arrowhead Pharmaceuticals, Inc. - the sum of all of the cash a company has on the date of report. Current cash Arrowhead Pharmaceuticals, Inc. is 372 377 000 $
31/03/2021
31/12/2020
30/09/2020
30/06/2020
31/12/2019
30/09/2019
30/06/2019
31/03/2019
31/12/2018
30/09/2018
30/06/2018
31/03/2018
31/12/2017
30/09/2017
30/06/2017
Gross profit
Gross profit is the profit a company makes after deducting the costs of making and selling its products, or the costs of providing its services.
32 811 000 $
21 303 000 $
7 632 855 $
27 375 778 $
29 454 579 $
43 292 770 $
42 696 636 $
48 148 275 $
34 657 896 $
11 255 000 $
727 375 $
-
-
-
-
Cost of revenue
Cost of revenue is the total cost of producing and distributing of products and services of a company.
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Total revenue
Total revenue refers to the total receipts from sales of a given quantity of goods or services. It is the total income of a business and is calculated by multiplying the quantity of goods sold by the price of the goods.
32 811 000 $
21 303 000 $
7 632 855 $
27 375 778 $
29 454 579 $
43 292 770 $
42 696 636 $
48 148 275 $
34 657 896 $
11 255 000 $
727 375 $
650 125 $
3 509 821 $
8 713 786 $
9 342 498 $
Operating revenue
Operating revenue is revenue generated from a company's primary business activities. For example, a retailer produces revenue through merchandise sales, and a physician derives revenue from the medical services he/she provides.
-
-
-
-
29 454 579 $
43 292 770 $
42 696 636 $
48 148 275 $
34 657 896 $
11 255 000 $
727 375 $
650 125 $
3 509 821 $
8 713 786 $
9 342 498 $
Operating income
Operating income is an accounting figure that measures the amount of profit realized from a business's operations, after deducting operating expenses such as wages, depreciation and cost of goods sold (COGS).
-28 232 000 $
-24 054 000 $
-50 119 092 $
-15 945 862 $
-4 853 594 $
9 638 049 $
18 595 749 $
22 010 692 $
10 946 144 $
-11 169 109 $
-15 919 719 $
-15 034 059 $
-13 813 348 $
-10 250 213 $
-5 714 164 $
Net income
Net income is an entity's income minus cost of goods sold, expenses and taxes for an accounting period.
-26 818 000 $
-20 732 000 $
-48 432 715 $
-13 611 213 $
-2 673 728 $
11 704 905 $
20 335 708 $
23 896 982 $
12 037 253 $
-10 761 271 $
-15 606 017 $
-14 884 311 $
-13 198 878 $
-10 731 886 $
-5 519 741 $
R&D spending
Research and Development spending - cost of investigative activities to improve existing products and procedures or to lead to the development of new products and procedures.
43 026 000 $
35 077 000 $
42 001 893 $
31 364 134 $
23 373 616 $
23 386 305 $
19 291 710 $
20 798 628 $
16 989 043 $
15 993 880 $
12 052 653 $
12 002 354 $
8 431 903 $
8 280 406 $
6 906 016 $
Operating expense
An operating expense is an expenditure that a business incurs as a result of performing its normal business operations.
61 043 000 $
45 357 000 $
57 751 947 $
43 321 640 $
34 308 173 $
33 654 721 $
24 100 887 $
26 137 583 $
23 711 752 $
22 424 109 $
16 647 094 $
15 684 184 $
17 323 169 $
18 963 999 $
15 056 662 $
Current assets
Current assets is a balance sheet item that represents the value of all assets that can reasonably expect to be converted into cash within one year.
586 757 000 $
323 716 000 $
322 370 397 $
315 232 854 $
507 614 372 $
265 246 817 $
244 538 724 $
234 970 345 $
248 950 613 $
78 768 598 $
61 870 095 $
92 660 460 $
53 106 877 $
67 902 904 $
77 902 394 $
Total assets
Total assets refers to the total amount of assets owned by a person or entity.
756 795 000 $
499 251 000 $
522 503 743 $
555 728 072 $
587 601 634 $
349 845 437 $
336 828 445 $
333 940 433 $
340 947 388 $
111 609 951 $
112 903 027 $
126 998 915 $
88 220 493 $
104 022 280 $
115 081 549 $
Current cash
Current cash - the sum of all of the cash a company has on the date of report.
372 377 000 $
139 921 000 $
143 582 667 $
219 322 617 $
461 032 249 $
221 804 128 $
188 331 747 $
161 639 208 $
189 772 981 $
30 133 213 $
27 995 386 $
69 805 117 $
11 531 345 $
24 838 567 $
38 383 135 $
Current debt
Current debt is the portion of debt due within a year (12 months) and is listed as a current liability and part of net working capital.
-
-
-
-
73 695 268 $
97 070 679 $
87 087 065 $
101 812 390 $
134 611 773 $
12 364 951 $
7 127 120 $
216 027 $
212 233 $
208 506 $
204 844 $
Total cash
Total cash - the sum of all of the cash a company has on its books, including petty cash and funds on deposit in a bank.
-
-
-
-
-
-
-
-
-
-
-
91 541 937 $
50 700 721 $
65 608 106 $
75 137 889 $
Total debt
Total debt is a combination of both short-term and long-term debt. Short-term debts are those that must be paid back within a year. Long-term debt generally includes every liability that must be paid off in more than a year.
-
-
-
-
88 072 991 $
105 809 185 $
111 158 405 $
133 300 197 $
169 447 357 $
16 368 950 $
11 143 668 $
2 431 118 $
2 482 775 $
2 533 524 $
2 583 382 $
Debt ratio
Total debt to total assets - is a financial ratio that indicates the percentage of a company's assets that are provided via debt.
-
-
-
-
14.99 %
30.24 %
33 %
39.92 %
49.70 %
14.67 %
9.87 %
1.91 %
2.81 %
2.44 %
2.24 %
Shareholders equity
Shareholder's equity (SE) is the owner's claim after subtracting total liabilities from total assets.
445 549 000 $
454 472 000 $
461 779 132 $
493 140 393 $
500 083 831 $
244 591 440 $
226 225 228 $
201 195 424 $
172 055 219 $
95 796 189 $
102 314 547 $
114 270 270 $
70 754 498 $
81 422 350 $
90 097 472 $
Cash flow
Cash flow is the net amount of cash and cash-equivalents being transferred into and out of a business.
-
-
-
-
-23 530 458 $
13 809 906 $
10 526 762 $
-19 586 508 $
168 284 763 $
-2 680 318 $
-14 409 165 $
-15 443 454 $
-14 690 480 $
-9 203 474 $
-10 409 632 $
Last revenue report of Arrowhead Pharmaceuticals, Inc. was 31/03/2021. According to last financial report total revenue in Arrowhead Pharmaceuticals, Inc. was 32 811 000 US dollar and changed by -31.854% since last year. Net income in Arrowhead Pharmaceuticals, Inc. was -26 818 000 $ in last quartal, net income changes to -212.223%.
Arrowhead Pharmaceuticals, Inc. stocks data
ARWR stock price
Arrowhead Pharmaceuticals, Inc. stock price today, ARWR stock quote.
